NDC 70771-1113

Doxazosin

Doxazosin

Doxazosin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Doxazosin Mesylate.

Product ID70771-1113_48bd7791-467c-44e8-8c3a-fb1de8a4afa9
NDC70771-1113
Product TypeHuman Prescription Drug
Proprietary NameDoxazosin
Generic NameDoxazosin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2017-08-31
Marketing CategoryANDA / ANDA
Application NumberANDA208719
Labeler NameZydus Lifesciences Limited
Substance NameDOXAZOSIN MESYLATE
Active Ingredient Strength2 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70771-1113-0

1000 TABLET in 1 BOTTLE (70771-1113-0)
Marketing Start Date2017-08-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70771-1113-1 [70771111301]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA208719
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-31

NDC 70771-1113-3 [70771111303]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA208719
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-31

NDC 70771-1113-2 [70771111302]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA208719
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-31

NDC 70771-1113-0 [70771111300]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA208719
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-31

NDC 70771-1113-4 [70771111304]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA208719
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-08-31

Drug Details

Active Ingredients

IngredientStrength
DOXAZOSIN MESYLATE2 mg/1

OpenFDA Data

SPL SET ID:ac889877-133c-4448-af5a-d77b3cbfe878
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197628
  • 197625
  • 197627
  • 197626

    • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "Doxazosin" or generic name "Doxazosin"

    NDCBrand NameGeneric Name
    0093-2067DoxazosinDoxazosin Mesylate
    0093-2068DoxazosinDoxazosin Mesylate
    0093-2069DoxazosinDoxazosin Mesylate
    0093-2070DoxazosinDoxazosin Mesylate
    0378-4021Doxazosindoxazosin mesylate
    0378-4022Doxazosindoxazosin mesylate
    0378-4024Doxazosindoxazosin mesylate
    0378-4028Doxazosindoxazosin mesylate
    0615-5536DoxazosinDoxazosin mesylate
    0615-5537DoxazosinDoxazosin mesylate
    0615-6570DoxazosinDoxazosin mesylate
    0615-6571DoxazosinDoxazosin mesylate
    0832-0356DoxazosinDoxazosin Mesylate
    0832-0357DoxazosinDoxazosin Mesylate
    0832-1358DoxazosinDoxazosin Mesylate
    0832-1359DoxazosinDoxazosin Mesylate
    68071-1889DoxazosinDoxazosin
    68071-4273DoxazosinDoxazosin
    68071-3298DoxazosinDoxazosin
    68071-3331DoxazosinDoxazosin
    68071-3341DoxazosinDoxazosin
    68071-4272DoxazosinDoxazosin
    68084-862DoxazosinDoxazosin
    68084-836DoxazosinDoxazosin
    68084-851DoxazosinDoxazosin
    68382-783DoxazosinDoxazosin
    68382-785DoxazosinDoxazosin
    68382-784DoxazosinDoxazosin
    68382-786DoxazosinDoxazosin
    68645-464DoxazosinDoxazosin
    68645-465DoxazosinDoxazosin
    68645-463DoxazosinDoxazosin
    68788-7149DoxazosinDoxazosin
    68788-7328DoxazosinDoxazosin
    68788-9675DoxazosinDoxazosin
    70518-0839DoxazosinDoxazosin
    70518-1061DoxazosinDoxazosin
    70518-1645DoxazosinDoxazosin
    70518-1560DoxazosinDoxazosin
    70518-1804DoxazosinDoxazosin
    70771-1115DoxazosinDoxazosin
    70771-1114DoxazosinDoxazosin
    70771-1112DoxazosinDoxazosin
    70771-1113DoxazosinDoxazosin
    71335-0309DoxazosinDoxazosin
    71335-0349DoxazosinDoxazosin
    71335-0002DoxazosinDoxazosin
    71610-153DoxazosinDoxazosin
    71610-160DoxazosinDoxazosin
    71610-043DoxazosinDoxazosin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.